Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2

Skip to main content

Contracts Grants Pricing Blog Glossary

Loading...

Kontrakk

The only workspace built for the work of government contracting.

Platform

Discovery feed
Pursuit board
Grants

Industries

Federal contractors
Defense primes
Nonprofit grants
Higher education

Resources

Help center
Developer docs

Company

About
Privacy
Terms of Service

© 2026 Kontrakk. All rights reserved.Government Contracts. Won with Confidence.

Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2

Home
Grants
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2

Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2

forecasted

forecast

#RFA-DA-28-001

Agency

National Institutes of Health

Code: HHS-NIH11

Description

No description available

Important Dates

Open Date

Aug 20, 2026

CFDA Numbers

93.279

View on Grants.gov

More grants from National Institutes of Health

Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC)
National Institutes of Health
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics
National Institutes of Health
Multimodal AI to Accelerate Precision Medicine for Type 1 Diabetes (U01- Clinical Trials Not Allowed)
National Institutes of Health
Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed)
National Institutes of Health
Closes May 26, 2029
Limited Competition: Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) (P30 - CT Optional)
National Institutes of Health
Closes May 30, 2029